Noida: Jubilant Life Sciences Limited, an integrated global Pharmaceutical and Life Sciences Company, has announced a price increase of 10 percent for its Vitamin B3 (Niacin and Niacinamide) with immediate effect, for non-contract customers and wherever existing contracts permit.
Jubilant is the second largest producer of Vitamin B3 globally. The Vitamin B3 business is part of its Life Science Ingredients (LSI) segment, which offers a broad portfolio of high-quality ingredients that find application in wide range of industries.
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans